Sec. 107. GAO STUDY
180 words·~1 min read·
/statute-compilations/comps-10691/sec-107A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 107 GAO STUDY ###
(a)Study Not later than 36 months after the date of the enactment of this Act, the Comptroller General of the United States shall submit to Congress a report on pharmacy compounding and the adequacy of State and Federal efforts to assure the safety of compounded drugs. ###
(b)Contents The report required under this section shall include— ####
(1)a review of pharmacy compounding in each State, and the settings in which such compounding occurs; ####
(2)a review of the State laws and policies governing pharmacy compounding, including enforcement of State laws and policies; ####
(3)an assessment of the available tools to permit purchasers of compounded drugs to determine the safety and quality of such drugs; ####
(4)an evaluation of the effectiveness of the communication among States and between States and the Food and Drug Administration regarding compounding; and ####
(5)an evaluation of the Food and Drug Administration’s implementation of sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. # TITLE II DRUG SUPPLY CHAIN SECURITY